GERN – Geron Corporation
Float Short %
11.73
Margin Of Safety %
Put/Call OI Ratio
0.46
EPS Next Q Diff
EPS Last/This Y
0.15
EPS This/Next Y
0.09
Price
1.4
Target Price
3.6
Analyst Recom
2
Performance Q
11.02
Relative Volume
1.4
Beta
0.62
Ticker: GERN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | GERN | 1.365 | 0.22 | 0.19 | 111701 |
| 2025-12-29 | GERN | 1.365 | 0.22 | 0.02 | 112133 |
| 2025-12-30 | GERN | 1.335 | 0.22 | 0.39 | 112409 |
| 2025-12-31 | GERN | 1.325 | 0.22 | 0.03 | 112450 |
| 2026-01-02 | GERN | 1.325 | 0.22 | 0.45 | 112472 |
| 2026-01-05 | GERN | 1.315 | 0.23 | 0.00 | 113388 |
| 2026-01-06 | GERN | 1.31 | 0.23 | 0.00 | 113430 |
| 2026-01-07 | GERN | 1.365 | 0.23 | 0.04 | 114281 |
| 2026-01-08 | GERN | 1.365 | 0.23 | 0.01 | 114537 |
| 2026-01-09 | GERN | 1.335 | 0.23 | 0.32 | 114550 |
| 2026-01-12 | GERN | 1.43 | 0.23 | 0.12 | 114997 |
| 2026-01-13 | GERN | 1.315 | 0.23 | 0.53 | 116083 |
| 2026-01-14 | GERN | 1.35 | 0.23 | 0.15 | 116319 |
| 2026-01-15 | GERN | 1.3 | 0.23 | 0.05 | 116722 |
| 2026-01-16 | GERN | 1.3 | 0.22 | 0.21 | 117644 |
| 2026-01-20 | GERN | 1.305 | 0.50 | 0.19 | 58692 |
| 2026-01-21 | GERN | 1.335 | 0.49 | 0.00 | 60654 |
| 2026-01-22 | GERN | 1.405 | 0.46 | 0.14 | 63424 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | GERN | 1.37 | 1.7 | 54.6 | -0.12 |
| 2025-12-29 | GERN | 1.37 | 1.7 | 54.9 | -0.12 |
| 2025-12-30 | GERN | 1.34 | 1.7 | 54.6 | -0.12 |
| 2025-12-31 | GERN | 1.33 | 1.7 | 54.8 | -0.12 |
| 2026-01-02 | GERN | 1.33 | 1.7 | 55.0 | -0.12 |
| 2026-01-05 | GERN | 1.31 | 1.7 | 54.8 | -0.12 |
| 2026-01-06 | GERN | 1.32 | 1.7 | 54.9 | -0.12 |
| 2026-01-07 | GERN | 1.37 | 1.7 | 55.4 | -0.12 |
| 2026-01-08 | GERN | 1.37 | 1.7 | 54.9 | -0.12 |
| 2026-01-09 | GERN | 1.34 | 1.7 | 54.6 | -0.12 |
| 2026-01-12 | GERN | 1.42 | 1.7 | 55.7 | -0.12 |
| 2026-01-13 | GERN | 1.32 | 1.7 | 53.9 | -0.12 |
| 2026-01-14 | GERN | 1.35 | 1.7 | 55.3 | -0.12 |
| 2026-01-15 | GERN | 1.30 | 1.7 | 43.8 | -0.12 |
| 2026-01-16 | GERN | 1.30 | -26.4 | 43.7 | -0.12 |
| 2026-01-20 | GERN | 1.30 | -26.4 | 43.7 | -0.12 |
| 2026-01-21 | GERN | 1.34 | -26.4 | 43.7 | -0.12 |
| 2026-01-22 | GERN | 1.40 | -26.4 | 43.6 | -0.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | GERN | 0.00 | -1.06 | 12.52 |
| 2025-12-29 | GERN | 0.00 | -1.09 | 12.52 |
| 2025-12-30 | GERN | 0.00 | -1.09 | 12.52 |
| 2025-12-31 | GERN | 0.00 | -1.09 | 12.52 |
| 2026-01-02 | GERN | 0.00 | -1.09 | 12.52 |
| 2026-01-05 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-06 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-07 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-08 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-09 | GERN | 0.00 | -1.08 | 12.52 |
| 2026-01-12 | GERN | 0.00 | -1.09 | 12.52 |
| 2026-01-13 | GERN | 0.00 | -1.09 | 11.73 |
| 2026-01-14 | GERN | 0.00 | -1.09 | 11.73 |
| 2026-01-15 | GERN | 0.00 | -1.09 | 11.73 |
| 2026-01-16 | GERN | 0.00 | -1.09 | 11.73 |
| 2026-01-20 | GERN | 0.00 | -2.80 | 11.73 |
| 2026-01-21 | GERN | 0.00 | -2.80 | 11.73 |
| 2026-01-22 | GERN | 0.00 | -2.80 | 11.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.04
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
Institutional Transactions
-2.8
Beta
0.62
Average Sales Estimate Current Quarter
50
Average Sales Estimate Next Quarter
52
Fair Value
Quality Score
47
Growth Score
56
Sentiment Score
22
Actual DrawDown %
73.8
Max Drawdown 5-Year %
-79
Target Price
3.6
P/E
Forward P/E
PEG
P/S
4.91
P/B
3.62
P/Free Cash Flow
EPS
-0.12
Average EPS Est. Cur. Y
-0.12
EPS Next Y. (Est.)
-0.03
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-43.61
Relative Volume
1.4
Return on Equity vs Sector %
-59.4
Return on Equity vs Industry %
-43.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
43.6
Geron CorporationSector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading